Holen Sie sich die Stockscreener-App
3.57
1.38%
-0.05
Handel nachbörslich:
3.59
0.02
+0.56%
Schlusskurs vom Vortag:
$3.62
Offen:
$3.48
24-Stunden-Volumen:
1.81M
Relative Volume:
0.21
Marktkapitalisierung:
$57.15M
Einnahmen:
$1.38M
Nettoeinkommen (Verlust:
$-179.05M
KGV:
-0.5814
EPS:
-6.14
Netto-Cashflow:
$-155.03M
1W Leistung:
-12.93%
1M Leistung:
+40.55%
6M Leistung:
+32.22%
1J Leistung:
+495.00%
1-Tages-Spanne:
$3.48
$3.72
1-Wochen-Bereich:
$3.41
$4.20
52-Wochen-Spanne:
$0.16
$8.08
Bioxcel Therapeutics Inc Stock (BTAI) Company Profile
Firmenname
Bioxcel Therapeutics Inc
Sektor
Branche
Telefon
203-643-8060
Adresse
555 LONG WHARF DRIVE, NEW HAVEN, CT
Vergleichen Sie BTAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTAI
Bioxcel Therapeutics Inc
|
3.57 | 55.32M | 1.38M | -179.05M | -155.03M | -6.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioxcel Therapeutics Inc Stock (BTAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-21 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-15 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-07-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-03-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-01 | Hochstufung | Goldman | Sell → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-06 | Bestätigt | BofA Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-30 | Eingeleitet | Goldman | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-04 | Eingeleitet | Guggenheim | Buy |
| 2020-04-01 | Eingeleitet | BofA/Merrill | Buy |
| 2020-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-08 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
Alle ansehen
Bioxcel Therapeutics Inc Aktie (BTAI) Neueste Nachrichten
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Sector ETF performance correlation with BioXcel Therapeutics Inc.July 2025 Recap & Entry Point Confirmation Signals - Newser
Trend analysis for BioXcel Therapeutics Inc. this weekWeekly Profit Analysis & Growth Focused Investment Plans - Newser
Is BioXcel Therapeutics Inc. reversing from oversold territoryMarket Volume Summary & Low Risk Profit Maximizing Plans - Newser
Is BioXcel Therapeutics Inc. a speculative investmentMarket Trend Review & Target Return Focused Picks - khodrobank.com
What’s next for BioXcel Therapeutics Inc. stock2025 Fundamental Recap & Daily Chart Pattern Signals - khodrobank.com
What Fibonacci levels say about BioXcel Therapeutics Inc. reboundJuly 2025 Pullbacks & Safe Capital Growth Plans - Newser
Custom strategy builders for tracking BioXcel Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Is it too late to sell BioXcel Therapeutics Inc.Weekly Stock Report & Daily Volume Surge Trade Alerts - Newser
Using data models to predict BioXcel Therapeutics Inc. stock movement2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Will BioXcel Therapeutics Inc. stock recover after recent dropEarnings Summary Report & Daily Stock Momentum Reports - Newser
Risk vs reward if holding onto BioXcel Therapeutics Inc.Market Movement Recap & Step-by-Step Trade Execution Guides - Newser
Is BioXcel Therapeutics Inc. a strong candidate for buy and hold2025 Support & Resistance & Precise Swing Trade Alerts - khodrobank.com
Detecting price anomalies in BioXcel Therapeutics Inc. with AIAnalyst Upgrade & Growth Oriented Trading Recommendations - Newser
BioXcel Therapeutics Inc. stock momentum explained2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Risk adjusted return profile for BioXcel Therapeutics Inc. analyzedRecession Risk & Low Drawdown Investment Ideas - Newser
Can momentum traders help lift BioXcel Therapeutics Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - Newser
BioXcel Therapeutics' (BTAI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Can a trend reversal in BioXcel Therapeutics Inc. lead to recoveryWeekly Trade Analysis & Fast Gaining Stock Reports - Newser
Will BioXcel Therapeutics Inc. outperform the marketTrade Exit Summary & Consistent Growth Stock Picks - Newser
Can machine learning forecast BioXcel Therapeutics Inc. recoveryPortfolio Performance Report & High Return Trade Guides - Newser
Is BioXcel Therapeutics Inc. stock poised for growthJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Will BioXcel Therapeutics Inc. benefit from green energy policies2025 Short Interest & Reliable Volume Spike Alerts - khodrobank.com
Real time breakdown of BioXcel Therapeutics Inc. stock performancePortfolio Return Summary & Low Risk Growth Stock Ideas - Newser
Will BioXcel Therapeutics Inc. see short term momentumMarket Risk Report & Verified Technical Trade Signals - Newser
Is BioXcel Therapeutics Inc.’s growth already priced inJuly 2025 Trends & Weekly High Return Stock Forecasts - خودرو بانک
Is BioXcel Therapeutics Inc. Forming a Consolidation Base2025 Price Momentum & Accurate Intraday Trading Signals - beatles.ru
What data driven models say about BioXcel Therapeutics Inc.’s futureRisk Management & Free High Accuracy Swing Entry Alerts - Newser
How moving averages guide BioXcel Therapeutics Inc. tradingQuarterly Performance Summary & Low Risk High Win Rate Picks - Newser
Applying Wyckoff theory to BioXcel Therapeutics Inc. stockWeekly Gains Report & Community Verified Trade Alerts - Newser
Using portfolio simulators with BioXcel Therapeutics Inc. includedEarnings Recap Report & Weekly High Conviction Ideas - Newser
Using Bollinger Bands to evaluate BioXcel Therapeutics Inc.Quarterly Market Review & Consistent Profit Trading Strategies - Newser
Should you hold or exit BioXcel Therapeutics Inc. now2025 Trading Recap & AI Forecasted Entry/Exit Points - Newser
Will earnings trigger a reversal in BioXcel Therapeutics Inc.July 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Can trapped investors hope for a rebound in BioXcel Therapeutics Inc.Market Volume Summary & Consistent Return Investment Signals - Newser
What to do if you’re stuck in BioXcel Therapeutics Inc.2025 Investor Takeaways & Growth Focused Stock Pick Reports - Newser
Backtesting results for BioXcel Therapeutics Inc. trading strategiesJuly 2025 Institutional & Verified Swing Trading Watchlist - Newser
Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bioxcel Therapeutics Inc-Aktie (BTAI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mehta Vimal | CEO and President |
Dec 16 '24 |
Sale |
0.36 |
3,117 |
1,131 |
59,605 |
| Steinhart Richard I | Chief Financial Officer |
Dec 16 '24 |
Sale |
0.36 |
577 |
207 |
20,932 |
| Rodriguez Javier | See Remarks |
Dec 16 '24 |
Sale |
0.36 |
430 |
153 |
24,423 |
| Yocca Frank | Chief Scientific Officer |
Dec 16 '24 |
Sale |
0.35 |
430 |
152 |
28,931 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):